U.S. flag

An official website of the United States government

NM_000371.4(TTR):c.424G>A (p.Val142Ile) AND Amyloid Cardiomyopathy, Transthyretin-related

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Aug 18, 2011
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000030575.10

Allele description [Variation Report for NM_000371.4(TTR):c.424G>A (p.Val142Ile)]

NM_000371.4(TTR):c.424G>A (p.Val142Ile)

Gene:
TTR:transthyretin [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
18q12.1
Genomic location:
Preferred name:
NM_000371.4(TTR):c.424G>A (p.Val142Ile)
Other names:
V122I; p.V142I:GTC>ATC
HGVS:
  • NC_000018.10:g.31598655G>A
  • NG_009490.1:g.11889G>A
  • NM_000371.4:c.424G>AMANE SELECT
  • NP_000362.1:p.Val142Ile
  • NP_000362.1:p.Val142Ile
  • LRG_416t1:c.424G>A
  • LRG_416:g.11889G>A
  • LRG_416p1:p.Val142Ile
  • NC_000018.9:g.29178618G>A
  • NM_000371.3:c.424G>A
  • P02766:p.Val142Ile
  • c.424G>A
  • p.V122I
  • p.VAL142ILE
Protein change:
V142I; VAL122ILE
Links:
UniProtKB: P02766#VAR_007600; OMIM: 176300.0009; dbSNP: rs76992529
NCBI 1000 Genomes Browser:
rs76992529
Molecular consequence:
  • NM_000371.4:c.424G>A - missense variant - [Sequence Ontology: SO:0001583]
Observations:
6

Condition(s)

Name:
Amyloid Cardiomyopathy, Transthyretin-related (ICA)
Synonyms:
Isolated Cardiac Amyloidosis
Identifiers:
MedGen: C3151471

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000053250Women's Health and Genetics/Laboratory Corporation of America, LabCorp
criteria provided, single submitter

(LabCorp Variant Classification Summary - May 2015)
pathogenic
(Aug 18, 2011)
germlinecuration, clinical testing

PubMed (18)
[See all records that cite these PMIDs]

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknown6not providednot providednot providednot providedclinical testing
not providedgermlineyes10not providednot provided10not providedcuration

Citations

PubMed

Genetic microheterogeneity of human transthyretin detected by IEF.

Altland K, Benson MD, Costello CE, Ferlini A, Hazenberg BP, Hund E, Kristen AV, Linke RP, Merlini G, Salvi F, Saraiva MJ, Singer R, Skinner M, Winter P.

Electrophoresis. 2007 Jun;28(12):2053-64.

PubMed [citation]
PMID:
17503405

Cardiac amyloidosis: report of a patient heterozygous for the transthyretin isoleucine 122 variant.

Saraiva MJ, Sherman W, Marboe C, Figueira A, Costa P, de Freitas AF, Gawinowicz MA.

Scand J Immunol. 1990 Oct;32(4):341-6.

PubMed [citation]
PMID:
2237288
See all PubMed Citations (18)

Details of each submission

From Women's Health and Genetics/Laboratory Corporation of America, LabCorp, SCV000053250.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided10not providednot providedcuration PubMed (18)
2not providednot providednot providednot providedclinical testing PubMed (18)
3not providednot providednot providednot providedclinical testing PubMed (18)
4not providednot providednot providednot providedclinical testing PubMed (18)
5not providednot providednot providednot providedclinical testing PubMed (18)
6not providednot providednot providednot providedclinical testing PubMed (18)
7not providednot providednot providednot providedclinical testing PubMed (18)

Description

"Common DV in African Americans causing Cardiac Amyloidosis; numbers entered here are fabricated to push the tbGP score to -3 since this is a known common DV; the review cited here states the following: "One particular mutation, Val122Ile, which is present in approximately 3% of African- Americans, causes restrictive cardiomyopathy in individuals usually after the age of 60. In this disease, in which neuropathy tends to be a minor factor and carpal tunnel syndrome the only neuropathic evidence of the disease, the diagnosis can be veryproblematic and any attempt to define penetrance is difficult.""

Description

Converted during submission to Pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyes10not providednot provided10not providednot providednot provided
2germlineunknownnot providedBloodassert pathogenicitynot providednot providednot provided See 2
3germlineunknownnot providedBloodassert pathogenicitynot providednot providednot providednot provided
4germlineunknownnot providedBloodassert pathogenicitynot providednot providednot providednot provided
5germlineunknownnot providedBloodassert pathogenicitynot providednot providednot provided See 5
6germlineunknownnot providedBloodassert pathogenicitynot providednot providednot provided See 6
7germlineunknownnot providedBloodassert pathogenicitynot providednot providednot providednot provided

Co-occurrences

#ZygosityAllelesNumber of Observations
2HomozygoteTTR:c.336+19G>A1
5SingleHeterozygoteTTR:c.336+19G>A1
6SingleHeterozygoteTTR:c.336+19G>A1

Last Updated: Sep 16, 2024